← FDA Drug Approvals (Drugs@FDA)
ERLOTINIB HYDROCHLORIDE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MSN · Approved 2021-05-10
Drug application
- FDA Application #
ANDA214366- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- ERLOTINIB HYDROCHLORIDE
- Generic name
- ERLOTINIB HYDROCHLORIDE
- Active ingredients
- ERLOTINIB HYDROCHLORIDE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- MSN
- Manufacturer
- Novadoz Pharmaceuticals LLC
- First approval
- 2021-05-10
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown